Silver

Silver

SCHEMBL4326545

N#Cc1ccc(S(=O)(=O)[O-])cc1.[Ag+]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Silver. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA2 P00918 7/20 0.55
CA1 P00915 6/20 0.55
CA9 Q16790 4/20 0.55
CA12 O43570 3/20 0.55
CYP19A1 P11511 2/20 0.48
RAD51 Q06609 1/20 0.47
MAOA P21397 2/20 0.44
MAOB P27338 2/20 0.44
IDO1 P14902 1/20 0.44
PTGS2 P35354 1/20 0.44
MAPT P10636 1/20 0.44
ALDH1A1 P00352 1/20 0.42
CYP2A6 P11509 1/20 0.42
CA3 P07451 1/20 0.42
CA6 P23280 1/20 0.42
CA14 Q9ULX7 1/20 0.42
BCHE P06276 1/20 0.42
ACHE P22303 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28445682 0.95 CA2 (0.55) CA2CA1CA9CA12CYP19A1
SCHEMBL6027013 0.89 CA1 (0.66) CA2CA1CA9CA12CYP19A1
SCHEMBL5078517 0.82 CA1 (0.56) CA2CA1CA9CA12RAD51
SCHEMBL4328680 0.82 MAPT (0.47) CA2CA1CA9CA12CYP19A1
SCHEMBL8514633 0.80 CA2 (0.59) CA2CA1CA9CA12CYP19A1
SCHEMBL1332778 0.78 CA2 (0.57) CA2CA1CA9CA12CYP19A1
SCHEMBL1894003 0.78 CA2 (0.57) CA2CA1CA9CA12CYP19A1
SCHEMBL9470548 0.77 ALDH1A1 (0.50) CA2CA1CA9CA12CYP19A1
Tetrabuthylammonium SCHEMBL1836140 0.77 KCNH2 (0.49) CA2CA1CA9CA12CYP19A1
SCHEMBL803901 0.76 PTGS2 (0.68) CA2CA1CA9CA12CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009091704-A2 AROMATIC FLUORINE-FREE PHOTOACID GENERATORS AND PHOTORESIST COMPOSITIONS CONTAINING THE SAME INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2009-07-23 WO disclosed
US-20090181319-A1 AROMATIC FLUORINE-FREE PHOTOACID GENERATORS AND PHOTORESIST COMPOSITIONS CONTAINING THE SAME INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2009-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181319-A1 AROMATIC FLUORINE-FREE PHOTOACID GENERATORS AND PHOTORESIST COMPOSITIONS CONTAINING THE SAME PFAS, AFF1, AFF2 CA2 1937/4885CA1 1548/4885CA9 1464/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.